Anne S. Eskildsen-Brems

Arhus, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.

A direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.

Journal: Breast cancer research and treatment

Published: January 27, 2025

A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients.

A nationwide observational study in heavily pretreated metastatic HER2-positive breast cancer patients.

Journal: Acta oncologica (Stockholm, Sweden)

Published: March 17, 2023

Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer.

Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer.

Journal: Acta oncologica (Stockholm, Sweden)

Published: December 01, 2020

The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer.

The NAME trial: a direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer.

Journal: Future oncology (London, England)

Published: June 20, 2019

Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients.

Efficacy and toxicity of eribulin treatment in metastatic breast cancer patients.

Journal: Acta oncologica (Stockholm, Sweden)

Published: August 14, 2018

Uniform Combretastatin-induced Effect on Monocytes and Neutrophils in Peripheral Blood but Not in Tumors.

Uniform Combretastatin-induced Effect on Monocytes and Neutrophils in Peripheral Blood but Not in Tumors.

Journal: Anticancer research

Published: May 13, 2015

A combretastatin-mediated decrease in neutrophil concentration in peripheral blood and the impact on the anti-tumor activity of this drug in two different murine tumor models.

A combretastatin-mediated decrease in neutrophil concentration in peripheral blood and the impact on the anti-tumor activity of this drug in two different murine tumor models.

Journal: PloS one

Published: March 17, 2013

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.

Journal: BJU international

Published: October 11, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026